摘要
目的研究囊泡分拣蛋白35(vacuolar protein sorting-35,VPS35)是否影响G蛋白偶联(G proteincoupled)的多巴胺受体D1 (Dopamine receptor D1)的降解过程及其机制。方法依据放线菌酮(cycloheximide,CHX)可以有效抑制生物体内蛋白的合成的原理,我们CHX处理细胞,来研究VPS35对DRD1的降解可能存在的影响。结果过表达VPS35之后,DRD1蛋白的降解速率比对照组加快了。相反的,在下调VPS35水平后,DRD1的降解速率减慢。另外,VPS35能加速DRD1的溶酶体和泛素蛋白酶体降解,但增加溶酶体降解的效果更加显著。结论(1) VPS35能够有效调控DRD1的降解速率;(2) VPS35主要通过溶酶体途径调控DRD1的降解。
Objective To study whether the vacuolar protein sorting-35( VPS35) could effect the process of degradation of G protein coupled receptor dopamine receptor D1( DRD1) and its possible mechanism. Methods Depend on the cycloheximide( CHX) can restrain the synthesis of the proteins of the organism effectively. We handle cells with CHX to study whether VPS35 effects the degradation of DRD1. Results VPS35 accelerates the degradation of DRD1 after over-expressing it in HEK 293 T cells. On the contrary,after knock-down the VPS35 level the rate of degradation of DRD1 was reduced. In addition,the VPS35 could accelerate the degradation of DRD1 through the pathway of lysosome and ubiquitin proteasome when the effect through pathway of lysosome is more significant. Conclusion VPS35 can regulate the degradation of DRD1 effectively mainly through the pathway of lysosome.
作者
王琛
肖乃安
马琪林
詹奕红
WAHG Chen;XIAO Naian;MA Qilin(Department of Neurology,The First Affiliated Hospital,School of Medicine,Xiamen University,Xiamen 361000,China)
出处
《中风与神经疾病杂志》
CAS
2019年第10期931-935,共5页
Journal of Apoplexy and Nervous Diseases
基金
厦门大学附属第一医院院内青年科研发展基金资助项目(XYY2016015)
厦门市科技重大专项:厦门市重大疾病急救技术研究及急救网络体专项-脑卒中综合诊疗技术研究及救治网络建设(3502Z20171005-20170801)
关键词
囊泡分拣蛋白35
多巴胺受体D1
降解
帕金森病
Vacuolar protein sorting-35
Dopamine receptor D1
Degradation
Parkinson’s disease